Personal information

Activities

Works (10)

Survival outcomes of adjuvant chemotherapy in patients with stage I pancreatic cancer stratified by pathologic risk

Surgery
2024-11 | Journal article
Contributors: Yiping Zou; Yongjie Xie; Jing Huang; Yuexiang Liang; Shaofei Chang; Hongwei Wang; Yifei Wang; Chuntao Gao; Xiuchao Wang; Tiansuo Zhao et al.
Source: check_circle
Crossref

Survival outcomes of neoadjuvant therapy followed by radical resection versus upfront surgery for stage I–III pancreatic ductal adenocarcinoma: a retrospective cohort study

International Journal of Surgery
2023-06 | Journal article
Contributors: Yiping Zou; Song Gao; Xin Yu; Tianxing Zhou; Yongjie Xie; Xiaofan Guo; Ran An; Xiuchao Wang; Tiansuo Zhao; Antao Chang et al.
Source: check_circle
Crossref

Hospital-Acquired Acute Kidney Injury in Older Patients: Clinical Characteristics and Drug Analysis

Gerontology
2022 | Journal article
Contributors: Wei Liu; Xing-ji Lian; Yuan-han Chen; Yi-ping Zou; Jie-shan Lin; Yan-hua Wu; Feng Yu; Wen-xue Hu; Wen-ke Hao
Source: check_circle
Crossref

Nomogram Based on Inflammatory Biomarkers to Predict the Recurrence of Hepatocellular Carcinoma—A Multicentre Experience

Journal of Inflammation Research
2022-09 | Journal article
Contributors: Zehao Zheng; Renguo Guan; Yiping Zou; Zhixiang Jian; Ye Lin; Rongping Guo; Haosheng Jin
Source: check_circle
Crossref

Construction of a Prognostic m6A-related lncRNA Signature to Predict Immunotherapy and Chemotherapy Response in Hepatocellular Carcinoma

2021-11-11 | Preprint
Contributors: Yiping Zou; Zhihong Chen; Hongwei Han; Qi Lou; Yuanpeng Zhang; Zhenrong Chen; Zuyi Ma; Haosheng Jin; Ning Shi
Source: check_circle
Crossref

SLC39A10 Upregulation Predicts Poor Prognosis, Promotes Proliferation and Migration, and Correlates with Immune Infiltration in Hepatocellular Carcinoma

Journal of Hepatocellular Carcinoma
2021-08 | Journal article
Contributors: Zuyi Ma; Zhenchong Li; Shujie Wang; Qi Zhou; Zuguang Ma; Chunsheng Liu; Bowen Huang; Zehao Zheng; LinLing Yang; Yiping Zou et al.
Source: check_circle
Crossref

Development and Validation of a Nomogram Based on Noninvasive Liver Reserve and Fibrosis (PALBI and FIB-4) Model to Predict Posthepatectomy Liver Failure Grade B-C in Patients with Hepatocellular Carcinoma

Journal of Oncology
2021-04-05 | Journal article
Contributors: Wenhui Zhong; Feng Zhang; Kaijun Huang; Yiping Zou; Yubin Liu; Cristina Magi-Galluzzi
Source: check_circle
Crossref

Identification of Prognostic and Therapeutic Biomarkers among FAM83 Family Members for Pancreatic Ductal Adenocarcinoma

Disease Markers
2021-03-01 | Journal article
Contributors: Zuyi Ma; Zixuan Zhou; Hongkai Zhuang; Zhenchong Li; Zuguang Ma; Bowen Huang; Chunsheng Liu; Yuanfeng Gong; Yiping Zou; Zehao Zheng et al.
Source: check_circle
Crossref

A Novel Prognostic Nomogram for Gallbladder Cancer after Surgical Resection: A Single-Center Experience

Journal of Oncology
2021-02-05 | Journal article
Contributors: Zuyi Ma; Fengying Dong; Zhenchong Li; Zehao Zheng; Zixuan Zhou; Hongkai Zhuang; Chunsheng Liu; Bowen Huang; Shanzhou Huang; Yiping Zou et al.
Source: check_circle
Crossref

Construction of Nomograms for Predicting Lung and Bone Metastases in Patients with Intrahepatic Cholangiocarcinoma and Identification of Patients Who Can Benefit from Chemotherapy

Journal of Oncology
2020-12-02 | Journal article
Contributors: Ning Shi; Yiping Zou; Yuanpeng Zhang; Hongwei Han; Zhihong Chen; Shiye Ruan; Liang Jin; Zuyi Ma; Zhenrong Chen; Qi Lou et al.
Source: check_circle
Crossref